BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37229882)

  • 1. Moderators of resistance-based exercise programs' effect on sarcopenia-related measures in men with prostate cancer previously or currently undergoing androgen deprivation therapy: An individual patient data meta-analysis.
    Lopez P; Newton RU; Taaffe DR; Winters-Stone K; Galvão DA; Buffart LM
    J Geriatr Oncol; 2023 Jun; 14(5):101535. PubMed ID: 37229882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
    Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
    BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial.
    Dawson JK; Dorff TB; Todd Schroeder E; Lane CJ; Gross ME; Dieli-Conwright CM
    BMC Cancer; 2018 Apr; 18(1):368. PubMed ID: 29614993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of resistance exercise on body composition and physical function in prostate cancer patients undergoing androgen deprivation therapy: an update systematic review and meta-analysis.
    Tian S; Ding M; Sun H
    Aging Male; 2022 Dec; 25(1):281-292. PubMed ID: 36382930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
    Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
    BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Use of Androgen Deprivation Therapy (ADT) in Men with Prostate Cancer Increase the Risk of Sarcopenia?
    Owen PJ; Daly RM; Dalla Via J; Mundell NL; Livingston PM; Rantalainen T; Fraser SF
    Calcif Tissue Int; 2019 Oct; 105(4):403-411. PubMed ID: 31317232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Exercise on Body Composition and Physical Performance in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy (ADT): A Narrative Synthesis.
    Logan L; Toohey K; Kavanagh PS; Paterson C; McKune AJ
    Semin Oncol Nurs; 2020 Oct; 36(5):151067. PubMed ID: 33010982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR.
    Galvão DA; Spry N; Denham J; Taaffe DR; Cormie P; Joseph D; Lamb DS; Chambers SK; Newton RU
    Eur Urol; 2014 May; 65(5):856-64. PubMed ID: 24113319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance Exercise Training, a Simple Intervention to Preserve Muscle Mass and Strength in Prostate Cancer Patients on Androgen Deprivation Therapy.
    Houben LHP; Beelen M; van Loon LJC; Beijer S
    Int J Sport Nutr Exerc Metab; 2024 Mar; 34(2):122-134. PubMed ID: 38048764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsiveness to Resistance-Based Multimodal Exercise Among Men With Prostate Cancer Receiving Androgen Deprivation Therapy.
    Taaffe DR; Newton RU; Spry N; Joseph DJ; Galvão DA
    J Natl Compr Canc Netw; 2019 Oct; 17(10):1211-1220. PubMed ID: 31590154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise Improves V˙O2max and Body Composition in Androgen Deprivation Therapy-treated Prostate Cancer Patients.
    Wall BA; GALVãO DA; Fatehee N; Taaffe DR; Spry N; Joseph D; Hebert JJ; Newton RU
    Med Sci Sports Exerc; 2017 Aug; 49(8):1503-1510. PubMed ID: 28319589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance training and reduction of treatment side effects in prostate cancer patients.
    Galvão DA; Nosaka K; Taaffe DR; Spry N; Kristjanson LJ; McGuigan MR; Suzuki K; Yamaya K; Newton RU
    Med Sci Sports Exerc; 2006 Dec; 38(12):2045-52. PubMed ID: 17146309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of exercise for muscle strength and physical function in men initiating ADT for prostate cancer.
    Newton RU; Galvão DA; Spry N; Joseph D; Chambers SK; Gardiner RA; Hayne D; Taaffe DR
    Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):457-464. PubMed ID: 32020032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
    Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
    Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Musculoskeletal Responses to Exercise Plus Nutrition in Men with Prostate Cancer on Androgen Deprivation: A 12-Month RCT.
    Dalla Via J; Owen PJ; Daly RM; Mundell NL; Livingston PM; Rantalainen T; Foulkes SJ; Millar JL; Murphy DG; Fraser SF
    Med Sci Sports Exerc; 2021 Oct; 53(10):2054-2065. PubMed ID: 33867499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Periodized Resistance Training on Skeletal Muscle During Androgen Deprivation Therapy for Prostate Cancer: A Pilot Randomized Trial.
    Dawson JK; Dorff TB; Tuzon C; Rice JC; Schroeder ET; Lane CJ; Gross ME; Dieli-Conwright CM
    Integr Cancer Ther; 2021; 20():15347354211035442. PubMed ID: 34301165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects and moderators of exercise medicine on cardiometabolic outcomes in men with prostate cancer previously or currently undergoing androgen deprivation therapy: An individual patient data meta-analysis.
    Lopez P; Newton RU; Taaffe DR; Winters-Stone K; Buffart LM; Galvão DA
    Crit Rev Oncol Hematol; 2023 Jun; 186():103995. PubMed ID: 37080399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer.
    Alberga AS; Segal RJ; Reid RD; Scott CG; Sigal RJ; Khandwala F; Jaffey J; Wells GA; Kenny GP
    Support Care Cancer; 2012 May; 20(5):971-81. PubMed ID: 21538098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial.
    Galvão DA; Taaffe DR; Spry N; Joseph D; Newton RU
    J Clin Oncol; 2010 Jan; 28(2):340-7. PubMed ID: 19949016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance Exercise Training Increases Muscle Mass and Strength in Prostate Cancer Patients on Androgen Deprivation Therapy.
    Houben LHP; Overkamp M; VAN Kraaij P; Trommelen J; VAN Roermund JGH; DE Vries P; DE Laet K; VAN DER Meer S; Mikkelsen UR; Verdijk LB; VAN Loon LJC; Beijer S; Beelen M
    Med Sci Sports Exerc; 2023 Apr; 55(4):614-624. PubMed ID: 36534950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.